Medtronic Jewels get FDA clearance:
This article was originally published in Clinica
The US FDA has cleared two of Medtronic's Jewel defibrillators for commercial release. Jewel models 7219C and 7202C use Medtronic's active can technology which, in clinical trials of 475 patients significantly lowered average defibrillation thresholds. The single Transvene lead system reduces extraneous electrical noise which could be misinterpreted by the circuitry, says Medtronic. Model 7202C offers cardioversion and defibrillation, while the 7219C also offers anti-tachycardia pacing.